Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Risk factors for gastrointestinal bleeding]

H Kutsumi1, S Fujimoto, K Rokutan

  • 1Division of Gastrointestinal Unit, Kyoto First Red Cross Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review article: Asia-Pacific consensus recommendations on endoscopic tissue acquisition for biliary strictures.

Alimentary pharmacology & therapeutics·2018
Same author

Para-psychobiotic Lactobacillus gasseri CP2305 ameliorates stress-related symptoms and sleep quality.

Journal of applied microbiology·2017
Same author

Beneficial effects of Lactobacillus casei strain Shirota on academic stress-induced sleep disturbance in healthy adults: a double-blind, randomised, placebo-controlled trial.

Beneficial microbes·2017
Same author

The effects of administration of the Lactobacillus gasseri strain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome.

Journal of applied microbiology·2016
Same author

Ultraconserved region-containing Transformer 2β4 controls senescence of colon cancer cells.

Oncogenesis·2016
Same author

Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models.

Neurogastroenterology and motility·2016
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Massive gastrointestinal bleeding poses a severe risk, especially for patients on hemodialysis or taking certain medications. Identifying and managing risk factors like hypertension and liver disease is crucial for effective prevention and treatment.

Area of Science:

  • Gastroenterology
  • Nephrology
  • Cardiology
  • Oncology

Context:

  • Massive gastrointestinal bleeding is a critical medical emergency.
  • Patients undergoing hemodialysis, anticoagulation/antiplatelet therapy, or with hypertension or liver disease are at increased risk.
  • Kyoto First Red Cross Hospital admitted 81 such patients in 1997.

Purpose:

  • To identify risk factors associated with massive gastrointestinal bleeding.
  • To emphasize the need for specialized prevention and treatment strategies for high-risk patient groups.

Summary:

  • 17% of patients with massive gastrointestinal bleeding were on hemodialysis.
  • 10% were on anticoagulants/antiplatelets, and 10% had hypertension treated with calcium antagonists.

Related Experiment Videos

  • 9% had liver cirrhosis and/or hepatocellular carcinoma.

    • Impact:

    • Highlights the importance of tailored interventions, such as heparin-free hemodialysis for active bleeding patients.
    • Suggests optimizing hemostatic therapy in anticoagulated patients to avoid thromboembolic events.
    • Recommends considering Helicobacter pylori eradication for high-risk groups to improve outcomes.